Pyk2 promotes Ang Ⅱ-induced cardiac hypertrophy in rat

Abstract

Abstract: Objective To investigate the role of proline-rich protein tyrosine kinase (Pyk2) in angiotensin Ⅱ(Ang Ⅱ)-induced cardiac hypertrophy and the underlying mechanism in rat. Methods Primary rat cardio-myocytes were isolated from rats and randomly divided into control group, Ang Ⅱ induction group (the dose of Ang Ⅱ was 100 nmol/L, cardiomyocytes were stimulated in the cell culture dish for 24 hours), Pyk2 inhibitor PF-431396 group (the dose of PF-431396 was 10 μmol/L, added to the cell culture dish 30 minutes in advance before Ang Ⅱ stimulation) and Ang Ⅱ induction group intervened by PF-431396 (the dose of Ang Ⅱ was 100 nmol/L, the dose of PF-431396 was 10 μmol/L). The size of cardiomyocytes was measured by α-actinin fluorescence staining. RT-qPCR was performed to detect the mRNA level of hypertrophic markers (ANP and β-MHC) in cardiomyocytes. The expressions of p-Pyk2, Pyk2 and p53 in cardiomyocytes were detected by Western blot analysis. Results Ang Ⅱ stimulation increased the surface area of cardiomyocytes and the mRNA level of hypertrophic markers(P＜0.05). In addition, the proteins of p-Pyk2 and p53 were increased(P＜0.05). However, after treatment of Pyk2 inhibitor PF-431396, moycardial hypertrophy was significantly improved and the protein level of Pyk2 and p53 decreased(P＜0.05). Conclusions Pyk2 promotes cardiomyocyte hypertrophy in rat induced by Ang Ⅱ through the p53 signaling pathway.

Key words: cardiac hypertrophy, angiotensin Ⅱ(Ang Ⅱ), proline-rich tyrosine kinase 2 (Pyk2)

CLC Number:

YAN Wen, LIU Li-xin, KONG Xiang-zhao, LUO Yu-chen, LI Zhong-qiu, LI Nan. Pyk2 promotes Ang Ⅱ-induced cardiac hypertrophy in rat[J]. Basic & Clinical Medicine, 2020, 40(3): 351-355.

References

[1]Jonsson S, Becirovic-Agic M, Isackson H, et al. Angiotensin Ⅱ and salt-induced decompensation in Balb/CJ mice is aggravated by fluid retention related to low oxidative stress[J]. Am J Physiol Renal Physiol, 2019, 316: F914-F933.
[2]Becirovic-Agic M, Jonsson S, Tveitaras MK, et al. Time-course of decompensation after angiotensin Ⅱ and high-salt diet in Balb/CJ mice suggests pulmonary hypertension-induced cardiorenal syndrome[J]. Am J Physiol Regul Integr Comp Physiol, 2019, 316: R563-R570.
[3]O-Uchi J, Jhun BS, Xu S, et al. Adrenergic signaling regulates mitochondrial Ca²⁺ uptake through Pyk2-dependent tyrosine phosphorylation of the mitochondrial Ca²⁺ uniporter[J]. Antioxid Redox Signal, 2014, 21: 863-879.
[4]You K, Huang Y, Zhang MC, et al. Control and prevention of myocardial fibrosis using Pyk2-related non-kinase[J]. Int J Clin Exp Med, 2015, 8: 18284-18292.
[5]Zhang K, Yan J, Wang L, et al. The Pyk2/MCU pathway in the rat middle cerebral artery occlusion model of ischemic stroke[J]. Neurosci Res, 2018, 131: 52-62.
[6]Stanzione R, Picascia A, Chieffi P, et al. Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression[J]. Lab Invest, 2001, 81: 51-59.
[7]Bayer AL, Ferguson AG, Lucchesi PA, et al. Pyk2 expression and phosphorylation in neonatal and adult cardiomyocytes[J]. J Mol Cell Cardiol, 2001, 33: 1017-1030.
[8]Lang D, Glukhov AV, Efimova T, et al. Role of Pyk2 in cardiac arrhythmogenesis[J]. Am J Physiol Heart Circ Physiol, 2011, 301: H975-983.
[9]Hu S, Cheng M, Guo X, et al. Down-regulation of miR-200c attenuates AngⅡ-induced cardiac hypertrophy via targeting the MLCK-mediated pathway[J]. J Cell Mol Med, 2019, 23: 2505-2516.
[10]Li N, Wang HX, Han QY, et al. Activation of the cardiac proteasome promotes angiotension Ⅱ-induced hypertrophy by down-regulation of ATRAP[J]. J Mol Cell Cardiol, 2015, 79: 303-314.
[11]Chinnakkannu P, Reese C, Gaspar JA, et al. Suppres-sion of angiotensin Ⅱ-induced pathological changes in heart and kidney by the caveolin-1 scaffolding domain peptide[J]. PLoS One, 2018, 13: e0207844.doi:10.1371/journal.pone.0207844.eCollection2018.
[12]Hernandez JS, Barreto-Torres G, Kuznetsov AV, et al. Crosstalk between AMPK activation and angiotensin Ⅱ-induced hypertrophy in cardiomyocytes: the role of mitochondria[J]. J Cell Mol Med, 2014, 18: 709-720.
[13]Huang CY, Pai PY, Kuo CH, et al. p53-mediated miR-18 repression activates HSF2 for IGF-ⅡR-dependent myocyte hypertrophy in hypertension-induced heart failure[J]. Cell Death Dis, 2017, 8: e2990. doi:10.10281/cddis.2017.320.
[14]Cheng YH, Hooker RA, Nguyen K, et al. Pyk2 regulates megakaryocyte-induced increases in osteoblast number and bone formation[J]. J Bone Miner Res, 2013, 28: 1434-1445.